Dose Escalation and Dose Expansion Study of Tirabrutinib in Combination With Other Targeted Anti-cancer Therapies in Adults With B-cell Malignancies
Clinical trial NCT02457598 · TERMINATED
Trial details
- NCT number
- NCT02457598
- Sponsor
- Gilead Sciences
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2015-06-16
- Primary completion
- 2024-09-25
- Enrollment
- 203
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.